New analysis

Nike Inc. NKE

Nike at 0.80x base IV is a wounded brand worth a measured bet.

Nike at 0.80x base IV is a wounded brand worth a measured bet.

Nike Inc. (NKE) · Analysis #1 · 5/3/2026

The composite scorecard reads 76 with the stock at $44.40 versus a base intrinsic value of $55.20 (px/IV 0.80). The Buffett franchise lens still works on Nike, but only if Elliott Hill restores wholesale trust, runs down clearance inventory, and stops the share-loss bleed to Hoka, On, and New Balance.

Plain English

Nike sells branded sneakers and athletic clothes worldwide. The previous boss tried to sell more directly online, hurt relationships with stores like Foot Locker, and stopped making the best running shoes. Hoka and On stole running. New Balance stole lifestyle. The new boss came out of retirement to fix it. The brand is still strong. The price ($44) is below what the business is worth ($55). But the moat is narrower than people think because anyone can switch sneakers tomorrow. Worth a measured bet, not a big one.

Thesis

Nike is the world's largest seller of athletic footwear and apparel, operating under the Nike, Jordan and Converse brands. The franchise is a textbook intangible-assets moat (per Damodaran [1] and Buffett's 1993 letter [6]) that has been temporarily impaired by a self-inflicted strategic error: under prior CEO John Donahoe, Nike accelerated a Direct-to-Consumer (DTC) pivot that cut wholesale shelf space at Foot Locker, DSG and specialty running, allowed innovation to stall in performance running, and let Hoka, On and New Balance occupy the vacated space. The 2024 reinstatement of Elliott Hill, a 32-year Nike veteran, is a credible 'return to founders' moment.

The scorecard supports a measured bet rather than conviction. Composite is 76; profitability subscore 16, balance sheet 22, capital allocation 19, valuation 19. ROIC 10y avg prints 0.0% in the dataset, owner earnings TTM are $3.55B, FCF conversion 0.893, P/E TTM 14.58 vs 10y avg 16.26, EV/FCF 10.98. Net debt/EBITDA at 6.14x looks alarming but reflects a depressed EBITDA denominator during the reset, not balance sheet distress; interest coverage is unreported but historically robust.

The critical math: at $44.40 the stock trades at 0.80x base IV ($55.20), 1.17x bear IV ($37.94), and 0.64x bull IV ($69.18). Reverse DCF implies 4.56% growth — a low bar Nike should clear if Hill merely stabilizes the brand. The owner manual works only if (a) wholesale partnerships are repaired without a permanent margin sacrifice, (b) running and global-football innovation pipelines reignite, and (c) Greater China stabilizes around current run-rate. If those three hold, $55–$70 is reasonable in three to five years; if any fails, $38 is reasonable. The price is interesting; the conviction must be sized accordingly.

Moat

Nike passes Munger's 4-test circle-of-competence filter: it sells branded sneakers and apparel, the same shape ten years ago and ten years forward, three identifiable profit drivers (Jordan brand, global running/basketball footwear, women's training/lifestyle), and it does not require predicting tech adoption curves, regulatory outcomes, or specific R&D outcomes. It does, however, require predicting consumer fad cycles — which is why the moat must be sized carefully.

  1. Intangibles (brand). This is the dominant moat. The Swoosh, the Jumpman, and the Air Jordan retro pipeline are among the most durable consumer marks in the world. Damodaran's framework [1] notes that brand value is a consequence of relentless brand stewardship, not a permanent endowment, and that managers who 'take over a valuable brand name and then dissipate its value, will reduce the values of the firm substantially' [1]. That is precisely the Donahoe-era critique: pulling product from wholesale, over-promoting on Nike.com, and starving running innovation diluted brand equity. Hill's job is to refill it. The brand still commands premium pricing on Air Force 1, Air Jordan, Dunk, and Pegasus; the question is whether new performance categories (running carbon-plate, trail, pickleball) re-engage. Verdict on intangibles: NARROW-to-WIDE depending on innovation velocity over the next 24 months.

  2. Cost advantages (scale). Nike contracts virtually all manufacturing to ~125 footwear factories and ~279 apparel factories across Vietnam, Indonesia, China, etc. Volume gives Nike best-in-class cost-per-unit, factory priority during shortages, and the ability to invest in proprietary materials (Flyknit, ZoomX). Damodaran [3] notes cost advantages 'in manufacturing' are a legitimate moat source. A new entrant with $10B over five years cannot replicate this supply chain — Adidas at ~half Nike's revenue still cannot match unit economics. Verdict: NARROW (real, but Nike's footwear gross margin advantage over On Holding is shrinking — On gets premium pricing without the scale).

  3. Distribution / shelf access. Nike has historically commanded the prime real estate at Foot Locker, Dick's, JD Sports, and global department stores. The Donahoe DTC pivot voluntarily gave this up. Hill is rebuilding it — the November 2024 letter to wholesale partners is a real reversal. This is closer to a destroyed moat being rebuilt than an existing one. Verdict on distribution: NARROW and improving, but Hoka and On now occupy permanent shelf positions that were Nike's.

  4. Switching costs. Essentially zero for the consumer. Damodaran [2] uses Microsoft Office as the canonical switching-cost example; sneakers are the opposite. A consumer can substitute Hoka Clifton for Pegasus tomorrow with no friction. This is the structural reason Nike's moat is fundamentally narrower than Coca-Cola's [6] — there is no recurring purchase lock-in. Verdict: NONE.

  5. Network effects. Limited. Athlete endorsements (LeBron, Serena retired, Kylian Mbappe, Sha'Carri Richardson) generate two-sided pull, but every competitor signs athletes. The Jordan brand is the closest to a network effect — culture begets culture — but it is fragile (cf. Yeezy/Adidas implosion).

Competitor stress test ($10B / 5 years): Adidas spent that decade trying and failed to overtake Nike. But Hoka went from $0 to $2B+ revenue in seven years, and On went from a 2010 startup to ~$2.5B revenue with premium gross margins — they did take share with much less than $10B. The moat is real but not impregnable.

Erosion risk: high in performance running, moderate in basketball (the Jordan retro program is structurally advantaged), low in lifestyle Air Force 1 / Dunk, moderate in women's training. Buffett's Coke/Gillette test [6] — has the leader increased worldwide market share recently? — Nike has lost footwear share each of the last three years. That is the bear's strongest data point.

Moat verdict: NARROW.

Management

Nike's capital allocation under Donahoe (2020–Oct 2024) was, in aggregate, poor. Under Elliott Hill (Oct 2024–present) it is too early to grade definitively, so this section grades the recent allocation and provides forward expectations.

  1. Reinvestment in the business. Donahoe-era reinvestment was misallocated — heavy spend on the Consumer Direct Acceleration tech stack, the Nike app ecosystem, and DTC fulfillment, while running innovation, performance product pipelines, and wholesale relationship investment were starved. The classic Damodaran failure mode [1] of 'managers who take over a valuable brand name and then dissipate its value.' Marketing efficiency declined; demand creation spend rose without proportional brand health gains. Grade on reinvestment: D.

  2. Acquisitions. Nike has been admirably restrained. Notable: Converse (2003), the analytics acquisitions Zodiac and Celect (2018, both quietly written down), RTFKT (2021, NFT-era acquisition that has since been folded back). RTFKT was a small but emblematic mistake — chasing a fad rather than core competency. Net acquisition record: passive but with one cycle-top mistake. Grade: B-.

  3. Debt. Net debt/EBITDA prints 6.14x in the scorecard, but this reflects depressed EBITDA during the reset, not absolute balance sheet stress. Nike has $9.4B long-term debt against a strong cash position; long-dated maturities; investment-grade rating. The leverage looks worse than it is. Hill is not adding leverage. Grade: B.

  4. Buybacks. This is where Nike's allocation history is most disappointing. Nike repurchased $4.6B in FY2024 and roughly $5.5B in FY2023 at average prices well above current $44 — meaningfully above what the IV-low $37.94 would have justified. The 10-year share count change is only -1.44%, which means the buyback program has functioned almost entirely to offset stock-based compensation rather than to retire shares. Buying near peak multiples (P/E 25–30 in 2021–2022) and slowing as the stock collapsed is the textbook bad pattern. Average P/IV at repurchase appears materially > 1.0. Grade on buybacks: D.

  5. Dividends. Nike has raised the dividend annually for over 20 years. Current yield ~2.1%. Payout ratio remains modest. This is the cleanest part of the allocation story. Grade: A-.

  6. Communication quality. Donahoe-era investor communication was promotional and downplayed wholesale damage until it was undeniable. The reset was forced on the company rather than self-disclosed. Hill's communication since October 2024 has been notably more direct: explicit acknowledgment that Nike 'lost its way' on running, explicit re-engagement with wholesale, and reset of guidance. This is closer to Buffett's preferred 'chairman who tells you what's wrong' tone. Grade on Hill-era communication: A-.

Management bench: Hill is a 32-year insider (joined 1988, retired 2020, returned 2024). Tom Peddie (wholesale), Heidi O'Neill (consumer/marketplace), and CFO Matt Friend remain. The 'return-of-the-founder' archetype is strong here — Bob Iger at Disney, Howard Schultz at Starbucks (cautionary tale), Steve Jobs at Apple. The variance of outcomes is wide.

Incentive alignment: management compensation is heavily equity-linked with multi-year performance vesting; insider ownership is modest but the Knight family still holds ~17% of voting power through Class A shares — meaningful skin in the game at the founder family level.

Net capital allocator grade: C+. The historical record over ten years rounds to C; the trajectory under Hill could plausibly be B+ if buyback discipline at sub-IV prices appears in FY26 disclosures and if marketing efficiency improves. Watch the next two annual reports for: (a) average buyback price, (b) demand creation as % of revenue trend, (c) inventory days, (d) wholesale revenue mix.

Capital allocator: C.

Industry

Athletic footwear and apparel sits at the consumer-discretionary intersection of fashion, performance, and athlete-driven culture. Porter's Five Forces:

  1. Threat of new entrants: HIGH and rising. The historical cost of entering athletic footwear was prohibitive (factories, athlete contracts, retail relationships). That has fallen dramatically. Hoka launched in 2009 and reached $2B+ revenue in 14 years. On Holding launched in 2010 and reached ~$2.5B. New Balance, long a sleepy regional player, has resurged via lifestyle (550, 990v6) without spending Nike-scale marketing. Direct-to-consumer plus social media plus contract manufacturing has compressed the time-to-credibility for a new athletic brand from 25 years to ~7. This is the single biggest negative structural change for Nike's moat.

  2. Bargaining power of buyers (consumers): MODERATE-HIGH. Switching costs are zero — a consumer choosing trail shoes can pick Hoka Speedgoat, Salomon, La Sportiva, or Nike Pegasus Trail with equal ease. Brand pull mitigates this for Nike's strongest franchises (Jordan, AF1, Dunk) where consumers seek the specific product, not the function. But for performance running specifically, function is winning over brand — and Nike has been functionally outclassed in non-elite running by Hoka cushioning and On's CloudTec since roughly 2020.

  3. Bargaining power of suppliers: LOW. Nike is a top-three customer for most of its 125 footwear factories. Vietnam concentration (~50% of footwear) creates geopolitical/tariff risk but not pricing power for suppliers. Cotton, rubber, and petrochemicals are commodity inputs with thin pass-through. Athletes are the one supplier category with leverage — top-tier endorsement contracts (Jordan estate, LeBron lifetime deal) cost hundreds of millions, and athlete leverage has risen as social media gives them direct fan relationships.

  4. Threat of substitutes: MODERATE. Within sneakers the substitutes are other sneakers, well-handled above. Outside sneakers, the substitute set has expanded: casual streetwear (Stussy, Aime Leon Dore), 'gorpcore' outdoor brands (Salomon, Arc'teryx Veilance), and the persistent return of the dress shoe / loafer in fashion cycles. None is existential.

  5. Industry rivalry: HIGH and intensifying. Adidas (Sambas, Gazelles, post-Yeezy reset), Puma (resurgent), New Balance (lifestyle on fire), Hoka (running dominance), On (premium-priced running and now lifestyle), Asics (running comeback), Lululemon (apparel adjacent, footwear nascent), and the long tail of streetwear collaborations all compete for the same consumer. Promotional intensity has risen. Inventory cycles industry-wide are extended.

Value pool location and trajectory: the value pool in athletic footwear is concentrated in performance innovation (carbon-plated running, trail, court) at the high-margin end and in lifestyle retro at the cultural-moment end. Nike has historically owned both. The performance-running pool has migrated to Hoka and On. The lifestyle retro pool remains Nike's, but is fashion-cyclical (the Dunk wave is 2.5 years old; the AF1 wave is permanent but not growing). Apparel value pool is migrating toward Lululemon and Vuori in women's. Roughly 30% of the value pool that was Nike's in 2018 has moved to challengers.

Industry Verdict: Average. Historically this was a Good industry for the leader; structural changes since 2018 have pulled it back to Average. Nike can still earn excess returns, but not as easily as during 1995–2018.

Inversion

Playing the short-seller. No hedging.

  1. The single event that kills this thesis. Elliott Hill is 65 years old and was retired before he was reinstated. He has 18–24 months of operational runway before the board needs a successor and before the market needs to see operating margin reflation. If, by FY27 (May 2027), running market share has not recovered, North America wholesale revenue has not stabilized, and gross margin has not climbed back above 45%, Hill will exit. The next CEO will be either another insider (continued mediocrity) or an external operator (multi-year reset). The single event: a FY27 guide that pushes margin recovery into FY28 and beyond. That moves the bear IV from $37.94 to the high $20s.

  2. Why the moat is narrower than bulls think. Bulls anchor on the Buffett 1993 framing [6] — Coke and Gillette, dominant brands, 'protective moat around their economic castle.' But Buffett was explicit about why those moats worked: recurring purchase, low ticket, habit-forming, and physical distribution density. Nike has none of those. Sneakers are a discretionary purchase made every 12–24 months; switching costs are zero; the consumer relationship runs through retailers Nike does not own; and the cultural arbiters of 'cool' (Gen Z TikTok, Hypebeast) have moved against legacy mass brands toward Hoka, Salomon, New Balance, On, and a long tail of niche labels. The intangibles moat that Damodaran describes [1] erodes when 'managers who take over a valuable brand name and then dissipate its value' — that has already happened, and the impairment is partially permanent because consumer mindshare is zero-sum. Hoka and On occupy mental real estate Nike used to own.

  3. Why management is worse than it appears. Hill is a sales-and-marketing lifer, not a product visionary. The Nike turnarounds that worked historically (1985 Air Jordan launch, 2000 Tiger Woods, 2017 Vaporfly) were product-led innovation breakthroughs. Hill's CV is wholesale relationships and brand storytelling — the distribution side. The deepest Nike problem is product: the running line has been beaten on cushioning, ride feel, and visual identity for half a decade. Fixing wholesale gets you back to where you were in 2019 minus the share that bled out. It does not get you to a new innovation cycle. The board chose the comfortable insider over a product-driven outsider, and that decision will look correct for 12–18 months and then look insufficient.

  4. What bulls are extrapolating that won't hold. Bulls extrapolate (a) Nike's 30-year ROIC profile resuming, (b) China returning to growth, (c) Jordan brand continuing to expand at 8–10%, (d) wholesale recovery without margin sacrifice. None is safe. (a) Industry ROICs converge [3]; Nike's normalized ROIC is structurally lower than its 2010s peak because category fragmentation is permanent. (b) Greater China is suffering both macro weakness and a consumer preference shift toward domestic brands (Anta, Li-Ning) that Nike management has consistently underestimated. (c) The Jordan brand is heavily exposed to retro releases; the supply of compelling new colorways of 30-year-old silhouettes is finite and the secondary-market price collapse since 2022 is a leading indicator. (d) Wholesale recovery requires margin concessions — Foot Locker is not extending shelf space without volume guarantees and promotional support that compress gross margin by 200–300 bps.

  5. Valuation trap (multiple compression / regime change). At $44.40 Nike trades at 14.58x trailing earnings versus 16.26x ten-year average. That looks cheap. It is not. Trailing earnings reflect a peak-of-cycle base — operating margin has compressed from 13–14% historically to ~10% in the current run rate, but the 'normalized' margin is plausibly 11–12%, not the 13–14% bulls extrapolate. Apply 14x to a normalized $3.20 EPS (vs the trailing $3.00 from current operations) and you get $45 — fair, not cheap. The multiple-expansion thesis (P/E expanding from 14 to 20 on 'recovery story') depends on the market re-rating Nike as a compounder. The market is unlikely to do that until two consecutive years of revenue growth + margin expansion + share gain, which is at minimum FY27. By then, the stock could be flat or down 15% as investors lose patience.

Furthermore, the scorecard's net-debt-to-EBITDA at 6.14x is not benign. Bulls dismiss it as a denominator effect during the reset. But if the reset takes longer than expected — and resets at this scale almost always do — the leverage ratio will not normalize before FY28, and the rating agencies will eventually take notice. A downgrade from A-rated to BBB+ would push Nike's borrowing costs higher, constrain buybacks, and remove one of the bull-case props. The owner earnings figure of $3.55B TTM is also flattered by working-capital release as the company runs down inventory; sustainable owner earnings are likely closer to $3.0B, putting the EV/owner-earnings multiple closer to 13x than the headline 11x.

Finally, the historical Buffett pattern Buffett warned about in the textile letters [Buffett 1980, Buffett 1985] is relevant: 'high-volume lines in which product differentiation was insignificant... could not generate adequate returns related to investment.' Nike's low-end commodity-shoe business (entry-price points, value channel) is the textile of athletic footwear. As mass-market consumers become more price-sensitive, that segment grows in revenue and shrinks in margin — a Buffett-warning footnote on the thesis.

If I am right, the stock could be worth $28 within 24 months.

Lollapalooza Bias Check

Biases active in me as the analyst right now.

  1. Authority bias. Nike is a name-brand 'great American company' covered by every sell-side desk; the Buffett-Munger framework [6] specifically holds up Coca-Cola as the archetype of a durable consumer brand, and there is a strong analyst tendency to file Nike under the same archetype. That filing is partially wrong — the structural difference (recurring purchase, switching costs, distribution lock) means Nike is not Coke. I am consciously discounting authority bias by inverting and writing the bear case first.

  2. Anchoring. The current price of $44.40 against an IV-base of $55.20 produces an obvious-looking 24% discount. I am anchored on that ratio. But IV-base is conditional on the maintenance-capex assumption being correct (the scorer flagged uncertainty >50%), and on the normalized-margin assumption being correct (also debatable). The honest range is probably IV-low $34 to IV-base $55, not $38 to $69. The visible discount may be smaller than it appears.

  3. Recency bias. The Hill reinstatement is recent and emotionally compelling — a 'return of the founder' narrative the press loves. Recency bias makes me overweight the probability that Hill executes well and underweight the base rate of insider-CEO turnarounds, which is roughly 40% successful at this scale (Iger-Disney yes, Schultz-Starbucks-2 no, Mulally-Ford yes, Lampert-Sears no).

  4. Confirmation bias. Once the thesis 'cheap brand at 0.80x IV with new CEO' is on the page, I notice supporting facts (wholesale relationships warming, dividend safety, Jordan brand resilience) and downweight contradicting facts (Greater China structural weakness, secondary-market Jordan price collapse, women's apparel share loss to Lululemon). The inversion section forces me to confront these.

  5. Social proof. Multiple respected value investors (Bill Ackman, Pershing Square reportedly took a stake) have publicly bought Nike at similar prices. Knowing this makes the trade feel safer than it is. Pershing Square is a large activist fund with a multi-year horizon and the ability to push for board changes; the retail or small-fund investor cannot replicate that lever.

  6. Commitment / consistency. Once an analyst writes 'compounder at attractive price' in a note, the analyst is biased toward holding the call as fundamentals deteriorate. I am pre-committing here: if North America wholesale revenue is not stabilizing and Greater China is not bottoming by the FY26 Q3 report, the recommendation must downgrade to Hold or Trim, regardless of where the stock is.

Not active: deprival super-reaction (no position to lose), incentive-caused bias (no comp tied to this call).

Net effect of biases: the active biases skew bullish. The inversion partially corrects this, but the residual skew supports a Buy rather than Strong Buy and conviction medium rather than high.

10-Year Outlook

The 10-year outlook test.

  1. Same fundamental business model in 2036? Yes, with high confidence. Nike will still be designing branded athletic footwear and apparel, contracting manufacture in Asia, and selling through a mix of DTC and wholesale. The category itself is durable — humans will buy sneakers in 2036.

  2. Customer base larger? Probably yes, modestly. Global middle-class growth continues; sport and athleisure participation continues to expand; women's athletic apparel continues to grow as a category. But Nike's share of that larger pie is the question — Nike could grow 3% while the category grows 5% and end the decade smaller in relative terms.

  3. Profit per customer higher? Uncertain. The historical pattern of Nike taking price each year and expanding gross margin is structurally weakened by competitive pressure (Hoka and On taking share at similar price points, New Balance taking share at lower price points). Average selling prices may rise with inflation, but unit gross margin expansion is unlikely. Real profit per customer is more likely flat than higher.

  4. Moat wider? No, narrower. The structural shifts of 2018–2026 (DTC compression of brand barriers, social media compression of marketing leverage, Vietnam supplier concentration risk) have all worked against Nike's moat. Hill can defend; he cannot widen.

  5. Single biggest threat? Category fragmentation accelerating. The historical pattern of one or two dominant brands (Nike + Adidas) holding 60%+ share globally is already breaking down. By 2036 the top-five players' combined share is likely lower than today's top-two share. Nike will still be #1 but with less pricing power.

Secondary threats: (a) Vietnam tariff or geopolitical event forcing supply-chain reset, (b) Greater China structural decline as domestic brands (Anta, Li-Ning) capture nationalist consumer preference, (c) AI-driven personalization tools eliminating the brand premium for performance running shoes (already happening — Strava and AI coach apps recommend by function, not logo).

Will the company exist and be larger in revenue in 2036? Almost certainly yes. Will it earn excess returns over its cost of capital? Probably yes, but at a lower spread than 2010–2020. Is the moat shape we are buying today the moat shape we will own in 2036? No — it will be narrower and more fashion-cyclical.

This is the canonical 'good business at a fair price, not a great business at any price' setup. The Hill turnaround thesis can deliver a 10–12% IRR over five years from $44, but the compounding-at-15%-for-decades thesis is broken.

CONFIDENCE: medium

Position Guidance

  • Recommendation: Buy
  • Conviction: Medium
  • Target buy price: $40 or below (1.05x IV-low of $37.94 — meaningful margin of safety against the bear case)
  • Target trim price: $66 or above (95% of IV-high $69.18 — bull-case IV approached)
  • Position sizing: 2-3% of portfolio at first entry; add a second 1-2% only if shares trade below $38 (below IV-low) AND wholesale revenue stabilizes in next two earnings reports. Maximum position 5%.
  • Required monitoring (quarterly): (1) North America wholesale revenue trend, (2) Greater China revenue and operating margin, (3) average buyback price, (4) inventory days, (5) running category share data from NPD/Circana.
  • Downgrade triggers: Hill departs before May 2027; or two consecutive quarters of accelerating wholesale decline; or gross margin below 42%; or buybacks resumed at >1.0x IV-base.